Protagonist Therapeutics, Inc. (PTGX)
144.83
+1.83
(+1.28%)
USD |
NASDAQ |
Sep 21, 11:42
Protagonist Therapeutics Price : 144.83 for Sept. 21, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 18, 2026 | 143.09 | 144.58 | 140.44 | 143.00 | 1.837M |
| Sep 17, 2026 | 144.39 | 146.50 | 142.31 | 143.70 | 558901.0 |
| Sep 16, 2026 | 144.19 | 146.19 | 140.88 | 142.84 | 507312.0 |
| Sep 15, 2026 | 147.48 | 147.99 | 142.00 | 143.40 | 637522.0 |
| Sep 14, 2026 | 150.23 | 151.24 | 146.83 | 147.78 | 608017.0 |
| Sep 11, 2026 | 147.18 | 150.48 | 145.82 | 148.18 | 478038.0 |
| Sep 10, 2026 | 143.29 | 146.51 | 142.00 | 145.16 | 543130.0 |
| Sep 09, 2026 | 146.05 | 151.18 | 144.46 | 145.09 | 530534.0 |
| Sep 08, 2026 | 143.61 | 147.29 | 142.00 | 145.94 | 700126.0 |
| Sep 04, 2026 | 146.47 | 147.99 | 144.01 | 145.72 | 501305.0 |
| Sep 03, 2026 | 146.68 | 149.49 | 144.00 | 148.80 | 354191.0 |
| Sep 02, 2026 | 148.00 | 149.42 | 144.61 | 146.08 | 561612.0 |
| Sep 01, 2026 | 147.75 | 150.34 | 144.72 | 146.49 | 534144.0 |
| Aug 31, 2026 | 143.26 | 149.30 | 141.95 | 147.75 | 567396.0 |
| Aug 28, 2026 | 147.73 | 147.95 | 142.43 | 144.33 | 501248.0 |
| Aug 27, 2026 | 150.35 | 151.68 | 147.11 | 149.50 | 381591.0 |
| Aug 26, 2026 | 150.36 | 152.07 | 147.69 | 151.50 | 335462.0 |
| Aug 25, 2026 | 155.84 | 157.98 | 150.09 | 150.59 | 664527.0 |
| Aug 24, 2026 | 154.32 | 158.08 | 149.94 | 154.72 | 483342.0 |
| Aug 21, 2026 | 152.10 | 154.95 | 150.82 | 154.32 | 402543.0 |
| Aug 20, 2026 | 152.45 | 155.25 | 148.28 | 150.69 | 518560.0 |
| Aug 19, 2026 | 160.81 | 160.81 | 154.22 | 154.94 | 786053.0 |
| Aug 18, 2026 | 157.96 | 160.00 | 156.81 | 157.34 | 471648.0 |
| Aug 17, 2026 | 155.11 | 158.95 | 153.60 | 158.62 | 506961.0 |
| Aug 14, 2026 | 150.23 | 155.53 | 149.17 | 155.10 | 426260.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| AbbVie, Inc. | 264.48 |
| Gilead Sciences, Inc. | 150.94 |
| Johnson & Johnson | 271.44 |
| Alnylam Pharmaceuticals, Inc. | 245.18 |
| BioMarin Pharmaceutical, Inc. | 64.18 |
Price Related Metrics
| PE Ratio | 139.66 |
| PS Ratio | 34.58 |
| PEG Ratio | 3.067 |
| Price to Book Value | 11.13 |
| Price to Free Cash Flow | 74.67 |
| Earnings Yield | 0.72% |
| Market Cap | 9.366B |
| PEGY Ratio | 3.067 |
| Operating PE Ratio | 167.13 |
| Normalized PE Ratio | 139.65 |